Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Invivyd, Inc. - Common Stock (NQ: IVVD ) 0.9001 +0.0076 (+0.85%) Streaming Delayed Price Updated: 3:07 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Invivyd, Inc. - Common Stock < Previous 1 2 3 4 5 6 7 Next > Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19 December 18, 2023 From Invivyd Via GlobeNewswire Recap: Invivyd Q3 Earnings November 09, 2023 Via Benzinga Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights November 09, 2023 From Invivyd Via GlobeNewswire Invivyd's Earnings: A Preview November 08, 2023 Via Benzinga Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights November 02, 2023 From Invivyd Via GlobeNewswire What 4 Analyst Ratings Have To Say About Invivyd June 23, 2023 Via Benzinga Invivyd to Participate in Upcoming Investor Conferences October 31, 2023 From Invivyd Via GlobeNewswire Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 September 11, 2023 Initial primary endpoint data anticipated in late 2023 or early Q1 2024 From Invivyd Via GlobeNewswire 7 Biotech Stocks to Sell in September Before They Crash & Burn September 06, 2023 These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. Via InvestorPlace Invivyd to Participate in Upcoming Investor Conferences September 06, 2023 From Invivyd Via GlobeNewswire Invivyd Appoints William Duke as Chief Financial Officer September 05, 2023 From Invivyd Via GlobeNewswire Bragar Eagel & Squire is Investigating Certain Officers and Directors of Dentsply, and Invivyd on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm August 16, 2023 From Bragar Eagel & Squire Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session August 10, 2023 Via Benzinga Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights August 10, 2023 From Invivyd Via GlobeNewswire Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights August 03, 2023 From Invivyd Via GlobeNewswire Invivyd Announces Appointment of Sara Cotter to Board Of Directors July 27, 2023 From Invivyd Via GlobeNewswire Earnings Scheduled For August 10, 2023 August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. Via Benzinga INVIVYD INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Invivyd, Inc. – IVVD, ADGI July 21, 2023 From Kahn Swick & Foti, LLC Via Business Wire Invivyd's COVID-19 Antibody Shows Favorable Safety, Tolerability Profile For Immunocompromised People July 17, 2023 Invivyd Inc (NASDAQ: IVVD) announced additional initial data from its ongoing Phase 1 healthy volunteer clinical trial of its lead investigational monoclonal Via Benzinga Invivyd Announces Additional Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People July 17, 2023 From Invivyd Via GlobeNewswire INVIVYD INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Invivyd, Inc. – IVVD, ADGI July 07, 2023 From Kahn Swick & Foti, LLC Via Business Wire Invivyd Announces General Alignment with FDA on Pathway to Potential EUA for VYD222 and Anticipated Follow-On Monoclonal Antibody Candidates Designed to Prevent COVID-19 June 26, 2023 From Invivyd Via GlobeNewswire Invivyd Says Investigational Antibody Shows Potential To Prevent Symptomatic COVID-19 June 22, 2023 Invivyd Inc (NASDAQ: IVVD) announces initial data from its ongoing Phase 1 healthy volunteer clinical trial of VYD222, its investigational monoclonal Via Benzinga Invivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People June 22, 2023 From Invivyd Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 01, 2023 Via Benzinga Invivyd to Participate at the Jefferies Healthcare Conference June 01, 2023 From Invivyd Via GlobeNewswire INVIVYD ALERT: Bragar Eagel & Squire, P.C. is Investigating Invivyd, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 26, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire NASDAQ:IVVD Long Term Investor Alert: Investigation over Potential Wrongdoing at Invivyd, Inc. May 25, 2023 San Diego, CA -- (SBWIRE) -- 05/25/2023 -- An investigation was announced on behalf of investors in shares of Invivyd, Inc. (NASDAQ:IVVD) over possible breaches of fiduciary duties by certain directors... Via SBWire Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 31, 2023 Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of... Via Benzinga Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 24, 2023 Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
